Skip to main content
. 2019 Apr-Jun;11(2):68–76. doi: 10.32607/20758251-2019-11-2-68-76

Fig. 1.

Fig. 1

Assessment of the efficacy of SBF-HS under conditions of single-cycle infection (TZM-bl cells and five HIV pseudoviruses). No statistical differences in the inhibition of pseudoviruses were observed between the tested batches of SBF-HS, except for the inhibition of the pseudovirus Q769.d22-PV between batches Nos. 2640516 and 2630416 (*) with p < 0.05